Status:
COMPLETED
Special Survey for Type 1 or Type 2 Diabetic Patients
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia episodes under normal clinical practice for patients with type 1 or type 2 diabetes.
Eligibility Criteria
Inclusion
- Patients with diabetes requiring insulin therapy
Exclusion
- Patients who had not been treated more than 3 months at the same investigational site
- Patients who had treatment history of NovoRapid® (insulin aspart)
Key Trial Info
Start Date :
April 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
1463 Patients enrolled
Trial Details
Trial ID
NCT01487408
Start Date
April 1 2002
End Date
October 1 2009
Last Update
March 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo, Japan, 1000005